InvestorsHub Logo
Followers 44
Posts 2710
Boards Moderated 0
Alias Born 03/11/2014

Re: None

Monday, 11/23/2020 12:50:40 AM

Monday, November 23, 2020 12:50:40 AM

Post# of 20303
Since the beginning of 2020, over 1,000 patients suffering from diseases caused by circulating coronaviruses in Israel have received various dosing regimens of Tollovid, including both hospitalized and non-hospitalized patients. There has been overwhelmingly positive
customer feedback on their experience with the product, including significant positive feedback from physicians
http://www.pharmaceuticaldaily.com/todos-medical-announces-positive-in-vitro-data-for-tollovid-confirming-3cl-protease-inhibition-mechanism-of-action/